Published February 28, 2026 | Version v1
Journal article Open

BOSWELLIC ACID: A MULTIFUNCTIONAL PHYTOCHEMICAL WITH PROMISING THERAPEUTIC POTENTIAL

Authors/Creators

Description

Boswellic acids, a class of pentacyclic triterpenes extracted from the gum resin of Boswellia species, have been recognized as bioactive compounds of significant pharmacological importance. People often call Boswellia serrata "Salai guggal." The resin part of Salai guggal is full of Boswellic acids, while the essential oil part is made up of a combination of mono-, di-, and sesquiterpenes. The gum part is mostly made up of pentose and hexose sugars. Traditional Chinese and Indian medicine practitioners use this oleo-gum resin a lot because it has a lot of useful biological properties. For example, it can reduce inflammation, arthritis, rheumatism, diarrhea, high cholesterol, asthma, cancer, and microbes, and it can also relieve pain. Boswellic acids have also been shown to be strong against viruses, cancer, and inflammation. It has been utilized as a natural remedy since prehistoric times to treat both acute and chronic conditions, including inflammatory illnesses. The goal of this study is to give an overview of boswellic acids' chemical structure, pharmacological profile, therapeutic potential, and formulation strategies. It will focus on current improvements in drug delivery systems that are meant to make them more effective and available.

Files

11 WJAPS 363.pdf

Files (584.0 kB)

Name Size Download all
md5:a732a51d940dca6ce8562213549a1c67
584.0 kB Preview Download

Additional details

Identifiers

ISSN
3049-3013

Related works

Is referenced by
Journal article: 3049-3013 (ISSN)

References

  • Ashish Garg, Ajay Shukla, Prakash Pandey, Suresh Dev, Inhibitory effect of alcoholic extract of Tulsi (Ocimum sanctum) on calcium oxalate crystals: An in-vitro study, Asian Journal of Pharmacy and Pharmacology, 2016; 3(2): 77-80.
  • Abdullah A. Elgazar, Ramadan A. El-Domany, Wagdy M. Eldehna, and Farid A. Badria ACS Omega, 2023; 8(42): 39490-39510. DOI: 10.1021/acsomega.3c05247
  • Farah Iram, Shah Alam Khan, Asif Husain, Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review, Asian Pacific Journal of Tropical Biomedicine, 2017; 7(6): 513-523. https://doi.org/10.1016/j.apjtb.2017.05.001.)
  • Gong, Y., et al. (2022). Biological activity of 3-O-acetyl-11-keto-β-boswellic acid: a comprehensive review. Molecules, 27(8): 2504.
  • Hussain, H., Wang, D., El-Seedi, H. R., Rashan, L., Ahmed, I., Abbas, M., … Shah, S. T. A. (2024). Therapeutic potential of boswellic acids: an update patent review (2016–2023). Expert Opinion on Therapeutic Patents, 34(8): 723–732. https://doi.org/10.1080/13543776.2024.2369626
  • Kajal L. Jain, Pratim Kumar Choudhury, Maya Sharma, Suresh Dev, Preparation and evaluation of anti-acne herbal gel, European Journal of Biomedical and Pharmaceutical sciences, 2017; 4(10): 578-581.
  • Kimmatkar, N., Thawani, V., Hingorani, L., & Khiyani, R. (2003). Efficacy and tolerability of Boswellia serrata extract in the treatment of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled study. Phytomedicine, 10(1): 3–7.
  • Kirste, S., et al. (2011). Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors. Cancer, 117(18): 4096–4102.
  • Krishnaraju, A. V., et al. (2010). Safety and toxicological evaluation of Aflapin®: preclinical data. Toxicology Mechanisms and Methods, 20(8): 556–563.
  • Lalithakumari, K., et al. (2006). Toxicology and safety evaluation of enriched Boswellia serrata extract (5-Loxin®): subchronic studies. Toxicology International, 13(3): 195–203.
  • Majeed, A., Majeed, S., Narayanan, N. K., & Nagabhushanam, K. (2019). Clinical evaluation of Boswellia serrata extract in osteoarthritis management. Phytotherapy Research, 33(6): 1457–1468.
  • Majeed, A., Majeed, S., Narayanan, N. K., & Nagabhushanam, K. (2024). A standardized Boswellia serrata extract improves knee osteoarthritis within five days: a randomized, double-blind trial. Frontiers in Pharmacology, 15: 1–10.
  • Maya Sharma, Indrajeet Singhvi, Zainab Munawar Ali, Manish Kumar, Suresh Kumar Dev, Synthesis and biological evaluation of natural cyclic peptide, Future Journal of Pharmaceutical Sciences, 2018; 4: 220-228.
  • Ragab, E. A. (2023). The journey of boswellic acids from synthesis to therapy: origins, chemistry, derivatives, pharmacokinetics, and biological activity. Naunyn-Schmiedeberg's Archives of Pharmacology, 396: 589–612.
  • Rajnish Srivastava, P.K. Choudhury, Suresh Kumar Dev, Vaibhav Rathore. Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for In-vivo Anti-Parkinson's Activity, Recent Patents on Nanotechnology, 2022; 16(2): 139-159.
  • Safayhi, H., Sailer, E. R., & Ammon, H. P. T. (1996). 5-Lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Planta Medica, 62: 241–242.
  • Schmiech, M., et al. (2024). Comparative pharmacokinetics of standardized Boswellia extracts. European Journal of Drug Metabolism and Pharmacokinetics, 49(3): 321–330.
  • Sengupta, K., Alluri, K. V., Satish, A. R., Mishra, S., Golakoti, T., & Sarma, K. V. (2008). A double-blind, randomized, placebo-controlled study of 5-Loxin® for treatment of osteoarthritis. Arthritis Research & Therapy, 10(4): R85.
  • Sengupta, K., Krishnaraju, A. V., Vishal, A. A., Mishra, A., Trimurtulu, G., & Sarma, K. V. (2010). Comparative efficacy and tolerability of Aflapin® and 5-Loxin® against osteoarthritis of the knee. International Journal of Medical Sciences, 7(6): 366–377.
  • Sharma, S., Thawani, V., Hingorani, L., & Khiyani, R. (2004). Pharmacokinetic study of 11-keto-β-boswellic acid. Phytomedicine, 11(2-3): 255–260.
  • Skarke, C., Kuczka, K., Werz, O., & Schubert, A. (2012). Bioavailability of 11-keto-β-boswellic acid after oral frankincense extract administration. Journal of Clinical Pharmacology, 52(5): 758–764.
  • Suresh Kumar Dev, Maya Sharma, Rajnish Srivastava and Pratim Kumar Choudhury, (2017), Phytochemical and Pharmacological aspects of Sarcostemma acidum (Roxb.) Voigt, Journal of Pharmacy Research, 11(11): 1429-31.
  • Suresh Kumar Dev, P K Choudhury, Rajnish Srivastava, Maya Sharma (2018), Phytochemical characterization and antioxidant assessment of herbal extracts, Journal of Drug Delivery and Therapeutics, 2018; 8(4): 126-33.
  • Trivedi, V. L., et al. (2023). Anticancer properties of boswellic acids: mechanisms and preclinical evidence. Frontiers in Pharmacology, 14: 1123–1134.
  • Vaidya, N., et al. (2025). Efficacy and safety of Boswellia serrata and Apium graveolens in osteoarthritis: a translational trial. Pharmaceutical Research, 42(2): 120–129.
  • Vijayarani, K. R., et al. (2020). Enhanced bioavailability of boswellic acid by Piper longum: preclinical absorption study. Journal of Drug Delivery and Therapeutics, 10(3): 123–130.
  • Vishal, A. A., Mishra, A., & Raychaudhuri, S. P. (2011). Evaluation of early efficacy and safety of Aflapin® in osteoarthritis: a randomized study. International Journal of Medical Sciences, 8(7): 615–622.
  • Wang, Y., et al. (2024). Acetyl-11-keto-β-boswellic acid modulates secondary injury after spinal cord trauma via oxidative stress attenuation. CNS Neuroscience & Therapeutics, 30(5): 420–430.
  • Yu, G., et al. (2020). Clinical evidence for Boswellia serrata in osteoarthritis: a meta-analysis. BMC Complementary Medicine and Therapies, 20(1): 143.